Vitrolife (Q2 initial take): Soft top-line but strong and improving profitability - Redeye
Vitrolife's Q2 report came in mixed showing -1% organic sales growth which was offset by an elevated EBITDA profitability of 34% in the quarter, with the restructuring efforts starting to bear fruit.
ANNONS
Vitrolife's Q2 report came in mixed showing -1% organic sales growth which was offset by an elevated EBITDA profitability of 34% in the quarter, with the restructuring efforts starting to bear fruit.
